China Universal Asset Management Co., Ltd. Amylyx Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,188 shares of AMLX stock, worth $88,002. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,188
Previous 14,535
18.25%
Holding current value
$88,002
Previous $54,000
11.11%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
72.6MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$40.3 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$30.4 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$29.2 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$21.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$15.8 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $300M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...